Showing results (1-10 of 1,314) with videos related to
Sort By:
Pageof 132
The Journal of Clinical Endocrinology and Metabolism|January 18, 2022
Relation of Testosterone, Dihydrotestosterone, and Estradiol With Changes in Outcomes Measures in the Testosterone TrialsAlisa J Stephens-Shields, Peter J Snyder, Susan S Ellenberg, et al.Clinical Trials (London, England)|July 12, 2020
Clinical trials in the time of a pandemicSusan S EllenbergStatistics in Medicine|January 13, 2004
Analytical, practical and regulatory issues in prevention studiesSusan S EllenbergStatistics in Medicine|August 31, 2012
Current issues in clinical trials: standing on the shoulders of Jerome CornfieldSusan S EllenbergThe Journal of Clinical Endocrinology and Metabolism|August 14, 2020
Markers of Iron Flux during Testosterone-Mediated Erythropoiesis in Older Men with Unexplained or Iron-Deficiency AnemiaAndrew S Artz, Alisa J Stephens-Shields, Shalender Bhasin, et al.Coronary Artery Disease|November 12, 2015
The Cardiovascular Trial of the Testosterone Trials: rationale, design, and baseline data of a clinical trial using computed tomographic imaging to assess the progression of coronary atherosclerosisMoshrik Abd Alamir, Susan S Ellenberg, Ronald S Swerdloff, et al.Andrology|August 2, 2024
Modulation of circulating free testosterone fraction by testosterone, dihydrotestosterone, and estradiol during testosterone replacement therapyRavi Jasuja, Karol M Pencina, Brian Lawney, et al.Therapeutic Innovation & Regulatory Science|January 8, 2025
Interim Clinical Trial Data: Who Can See What, and When?Susan S Ellenberg, Yimei LiJournal of Cardiovascular Computed Tomography|September 5, 2020
ISCHEMIA trial - Failed intervention or failed stratification?Matthew J BudoffProgress in Cardiovascular Diseases|September 25, 2003
Atherosclerosis imaging and calcified plaque: coronary artery disease risk assessmentMatthew J BudoffPageof 132